NOVA ADVANCED TISSUE ENGINEERING LIMITED

Active Wigston

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
N

NOVA ADVANCED TISSUE ENGINEERING LIMITED

Research and experimental development on biotechnology

Founded 27 Nov 2017 Active Wigston, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 8 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 25 Nov 2025 Next due 9 Dec 2026 7 months remaining
Net assets £1 £0 2024 year on year
Total assets £1 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Martin House Gloucester Crescent Wigston Leicestershire LE18 4YL United Kingdom

Full company profile for NOVA ADVANCED TISSUE ENGINEERING LIMITED (11083393), an active company based in Wigston, United Kingdom. Incorporated 27 Nov 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
James Andrew Pitt WhiteDirectorBritishUnited Kingdom4027 Nov 2017Active
Karen Alison LeishmanSecretaryUnknownUnknown1 Jan 2024Active
Peter John Pitt WhiteDirectorBritishUnited Kingdom7827 Nov 2017Active

Shareholders

Shareholders (1)

Nova Bio-pharma Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 27 Nov 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent As Firm,voting Rights 75 To 100 Percent As Firm

Group Structure

Group Structure

NOVA ADVANCED TISSUE ENGINEERING LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
25 Nov 2025Confirmation StatementConfirmation statement made on 25 Nov 2025 with updates
12 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
25 Nov 2024Confirmation StatementConfirmation statement made on 25 Nov 2024 with no updates
2 Jan 2024OfficersAppointment of Mrs Karen Alison Leishman as director on 1 Jan 2024
8 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

25 Nov 2025 Confirmation Statement

Confirmation statement made on 25 Nov 2025 with updates

12 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

25 Nov 2024 Confirmation Statement

Confirmation statement made on 25 Nov 2024 with no updates

2 Jan 2024 Officers

Appointment of Mrs Karen Alison Leishman as director on 1 Jan 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

5 months ago on 8 Dec 2025

Confirmation statement made on 25 Nov 2025 with updates

5 months ago on 25 Nov 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 12 Dec 2024

Confirmation statement made on 25 Nov 2024 with no updates

1 years ago on 25 Nov 2024

Appointment of Mrs Karen Alison Leishman as director on 1 Jan 2024

2 years ago on 2 Jan 2024